South San Francisco, Calif. biotech firm diaDexus
just raised $9.2 million in sixth-round funding
from Scale Venture Partners
and Baker Brothers Advisors, according to peHUB. The company’s first and only product, the PLAC Test, is used to detect early indicators of risk for heart attack and stroke. If such conditions can be determined at an early stage, aggressive treatment can prevent possibly-fatal events from ever occurring, diaDexus claims.